Literature DB >> 34903861

Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms.

Matthew J Burke1,2,3, Sara M Romanella4,5, Lucia Mencarelli4,5, Rachel Greben6, Michael D Fox4,7,8, Ted J Kaptchuk9, Alvaro Pascual-Leone10,11,12, Emiliano Santarnecchi13,14.   

Abstract

There is growing evidence that placebo effects can meaningfully modulate the brain. However, there has been little consideration of whether these changes may overlap with regions/circuits targeted by depression treatments and what the implications of this overlap would be on measuring efficacy in placebo-controlled clinical trials. In this systematic review and meta-analysis, we searched PubMed/Medline and Google Scholar for functional MRI and PET neuroimaging studies of placebo effects. Studies recruiting both healthy subjects and patient populations were included. Neuroimaging coordinates were extracted and included for Activation Likelihood Estimation (ALE) meta-analysis. We then searched for interventional studies of transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS) for depression and extracted target coordinates for comparative spatial analysis with the placebo effects maps. Of 1169 articles identified, 34 neuroimaging studies of placebo effects were included. There were three significant clusters of activation: left dorsolateral prefrontal cortex (DLPFC) (x = -41, y = 16, z = 34), left sub-genual anterior cingulate cortex (sgACC)/ventral striatum (x = -8, y = 18, z = -15) and the right rostral anterior cingulate cortex (rACC) (x = 4, y = 42, z = 10). There were two significant deactivation clusters: right basal ganglia (x = 20, y = 2, z = 7) and right dorsal anterior cingulate cortex (dACC) (x = 1, y = -5, z = 45). TMS and DBS targets for depression treatment overlapped with the left DLPFC cluster and sgACC cluster, respectively. Our findings identify a common set of brain regions implicated in placebo effects across healthy individuals and patient populations, and provide evidence that these regions overlap with depression treatment targets. We model the statistical impacts of this overlap and demonstrate critical implications on measurements of clinical trial efficacy for this field.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34903861     DOI: 10.1038/s41380-021-01397-3

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  27 in total

1.  Meta-analysis of the functional neuroanatomy of single-word reading: method and validation.

Authors:  Peter E Turkeltaub; Guinevere F Eden; Karen M Jones; Thomas A Zeffiro
Journal:  Neuroimage       Date:  2002-07       Impact factor: 6.556

Review 2.  Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account.

Authors:  Yoni K Ashar; Luke J Chang; Tor D Wager
Journal:  Annu Rev Clin Psychol       Date:  2017-03-27       Impact factor: 18.561

3.  Knowledge Gaps in Placebo Research: With Special Reference to Neurobiology.

Authors:  Paul Enck; Bjoern Horing; Ellen Broelz; Katja Weimer
Journal:  Int Rev Neurobiol       Date:  2018-08-03       Impact factor: 3.230

Review 4.  Placebo and Nocebo Effects.

Authors:  Luana Colloca; Arthur J Barsky
Journal:  N Engl J Med       Date:  2020-02-06       Impact factor: 91.245

Review 5.  Placebo eff ects in psychiatry: mediators and moderators.

Authors:  Katja Weimer; Luana Colloca; Paul Enck
Journal:  Lancet Psychiatry       Date:  2015-03       Impact factor: 27.083

6.  The functional neuroanatomy of the placebo effect.

Authors:  Helen S Mayberg; J Arturo Silva; Steven K Brannan; Janet L Tekell; Roderick K Mahurin; Scott McGinnis; Paul A Jerabek
Journal:  Am J Psychiatry       Date:  2002-05       Impact factor: 18.112

7.  Activation likelihood estimation meta-analysis revisited.

Authors:  Simon B Eickhoff; Danilo Bzdok; Angela R Laird; Florian Kurth; Peter T Fox
Journal:  Neuroimage       Date:  2011-09-22       Impact factor: 6.556

Review 8.  Placebo response in studies of major depression: variable, substantial, and growing.

Authors:  B Timothy Walsh; Stuart N Seidman; Robyn Sysko; Madelyn Gould
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

Review 9.  The neuroscience of placebo effects: connecting context, learning and health.

Authors:  Tor D Wager; Lauren Y Atlas
Journal:  Nat Rev Neurosci       Date:  2015-07       Impact factor: 34.870

Review 10.  A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials.

Authors:  Laís B Razza; Adriano H Moffa; Marina L Moreno; Andre F Carvalho; Frank Padberg; Felipe Fregni; André R Brunoni
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-28       Impact factor: 5.067

View more
  1 in total

1.  Expectancy in placebo-controlled trials of psychedelics: if so, so what?

Authors:  Matt Butler; Luke Jelen; James Rucker
Journal:  Psychopharmacology (Berl)       Date:  2022-09-05       Impact factor: 4.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.